Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques

Copyright © 2024 Elsevier Inc. All rights reserved..

SARS-CoV-2 infection causes activation of endothelial cells (ECs), leading to dysmorphology and dysfunction. To study the pathogenesis of endotheliopathy, the activation of ECs in lungs of cynomolgus macaques after SARS-CoV-2 infection and changes in nicotinamide adenine dinucleotide (NAD) metabolism in ECs were investigated, with a focus on the CD38 molecule, which degrades NAD in inflammatory responses after SARS-CoV-2 infection. Activation of ECs was seen from day 3 after SARS-CoV-2 infection in macaques, with increases of intravascular fibrin and NAD metabolism-associated enzymes including CD38. In vitro, upregulation of CD38 mRNA in human ECs was detected after interleukin 6 (IL-6) trans-signaling induction, which was increased in the infection. In the presence of IL-6 trans-signaling stimulation, however, CD38 mRNA silencing induced significant IL-6 mRNA upregulation in ECs and promoted EC apoptosis after stimulation. These results suggest that upregulation of CD38 in patients with COVID-19 has a protective role against IL-6 trans-signaling stimulation induced by SARS-CoV-2 infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:594

Enthalten in:

Virology - 594(2024) vom: 20. Apr., Seite 110052

Sprache:

Englisch

Beteiligte Personen:

Nguyen, Cong Thanh [VerfasserIn]
Nakayama, Misako [VerfasserIn]
Ishigaki, Hirohito [VerfasserIn]
Kitagawa, Yoshinori [VerfasserIn]
Kakino, Akemi [VerfasserIn]
Ohno, Marumi [VerfasserIn]
Shingai, Masashi [VerfasserIn]
Suzuki, Yasuhiko [VerfasserIn]
Sawamura, Tatsuya [VerfasserIn]
Kida, Hiroshi [VerfasserIn]
Itoh, Yasushi [VerfasserIn]

Links:

Volltext

Themen:

0U46U6E8UK
CD38
Cynomolgus macaques
Endotheliopathy
Interleukin-6
Interleukin-6 trans-signaling
Journal Article
NAD
Nicotinamide adenine dinucleotide
RNA, Messenger
SARS-CoV-2

Anmerkungen:

Date Completed 09.04.2024

Date Revised 09.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.virol.2024.110052

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369975049